American Academy of Ophthalmology: FDA Approves Assessment Tool to Help Drive Innovation in Premium IOL Cataract Surgery
May 25, 2024
May 25, 2024
SAN FRANCISCO, California, May 25 -- The American Academy of Ophthalmology issued the following news release:
The U.S. Food and Administration (FDA) last week qualified the American Academy of Ophthalmology's patient-reported outcome measure for premium intraocular lenses (IOLs) as a Medical Device Development Tool (MDDT). The designation allows medical device sponsors to use the Academy's Assessment of IntraOcular Lens Implant Symptoms (AIOLIS) to clinically evaluate patients' perc . . .
The U.S. Food and Administration (FDA) last week qualified the American Academy of Ophthalmology's patient-reported outcome measure for premium intraocular lenses (IOLs) as a Medical Device Development Tool (MDDT). The designation allows medical device sponsors to use the Academy's Assessment of IntraOcular Lens Implant Symptoms (AIOLIS) to clinically evaluate patients' perc . . .